224 related articles for article (PubMed ID: 6299916)
21. [Primary liver carcinoma and markers of virus of type B hepatitis (author's transl)].
Pedreira JD; Vargas V; Vilaseca J; Esteban R; Hernández-Sánchez JM; Guardia J; Bacardi R
Med Clin (Barc); 1980 Jun; 75(2):58-60. PubMed ID: 6249978
[TBL] [Abstract][Full Text] [Related]
22. Correlation between e/anti e system and evolution of B virus chronic hepatitis in pediatric patients.
Calzia R; Giacchino R; Marazzi MG; Ciravegna B; Navone C; Bertorello C; Lanteri M; Jannuzzi C
Boll Ist Sieroter Milan; 1986; 65(1):1-5. PubMed ID: 3718677
[TBL] [Abstract][Full Text] [Related]
23. [System e in acute hepatitis B].
Esteban R; Pedreira JD; Guardia J; Martinez-Vazquez JM; Gallart T; Bacardi R
Sem Hop; 1978 Sep 8-15; 54(21-24):717-8. PubMed ID: 213838
[TBL] [Abstract][Full Text] [Related]
24. A comparison between hepatocellular carcinoma-developing and non-carcinoma-developing patients with cirrhosis over a long follow-up period.
Kobayashi K; Unoura M; Tanaka N; Hattori N
Hepatogastroenterology; 1990 Oct; 37(5):445-8. PubMed ID: 2174821
[TBL] [Abstract][Full Text] [Related]
25. Hepatoma development during long term follow-up period of liver cirrhosis.
Kobayashi K; Kumagai M; Kameda S; Sugimoto T; Suzuki K; Nishimura K; Kato Y; Sugioka G; Hattori N
Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):344-9. PubMed ID: 214985
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B problem in Thailand.
Pramoolsinsap C; Pukrittayakamee S; Desakorn V
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):219-28. PubMed ID: 3024326
[TBL] [Abstract][Full Text] [Related]
27. Delta agent and the etiology of hepatocellular carcinoma.
Trichopoulos D; Day NE; Tzonou A; Hadziyannis S; Kaklamani E; Sparos L; Muñoz N; Hatzakis A
Int J Cancer; 1987 Mar; 39(3):283-6. PubMed ID: 3028967
[TBL] [Abstract][Full Text] [Related]
28. HBeAg/anti-HBe and alpha-fetoproteins levels in primary hepatocellular carcinoma.
Liaw YF
Lancet; 1982 Dec; 2(8313):1458. PubMed ID: 6184587
[No Abstract] [Full Text] [Related]
29. Presence of HBsAg and anti-HBs in patients with primary liver cancer or hepatic metastases.
Nastac E; Stoian M; Iosipenco M; Iordache C
Virologie; 1985; 36(3):181-6. PubMed ID: 3000067
[TBL] [Abstract][Full Text] [Related]
30. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.
Karayiannis P; Fowler MJ; Lok AS; Greenfield C; Monjardino J; Thomas HC
J Hepatol; 1985; 1(2):99-106. PubMed ID: 2997321
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.
Sulaiman HA
Gastroenterol Jpn; 1989 Aug; 24(4):434-41. PubMed ID: 2550307
[TBL] [Abstract][Full Text] [Related]
32. Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.
Fujiyama S; Sagara K; Takano J; Iwaoka D; Deguchi T; Mizuno K; Ohtomo N
Gastroenterol Jpn; 1979 Dec; 14(6):604-10. PubMed ID: 230994
[TBL] [Abstract][Full Text] [Related]
33. Relationship of hepatitis B antigen in cirrhosis and hepatoma in Thailand. An etiological significance.
Chanuvati T; Viranuvatti V; Pongpipat D
Gastroenterology; 1975 May; 68(5 Pt 1):1261-4. PubMed ID: 47828
[TBL] [Abstract][Full Text] [Related]
34. Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients.
Theodoropoulos G; Hadzis G
Gastroenterol Jpn; 1985 Oct; 20(5):436-40. PubMed ID: 4076727
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of HBeAg and anti-HBe in blood donors with HBs antigenemia.
Sabău M; Demeter S
Virologie; 1978; 29(3):209-12. PubMed ID: 99868
[TBL] [Abstract][Full Text] [Related]
36. Orcein staining of hepatitis B surface antigen in paraffin sections of liver on autopsy cases.
Sakurai M; Miyaji T
Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):334-9. PubMed ID: 73335
[TBL] [Abstract][Full Text] [Related]
37. Evidence of viral replication in HBsAg positive patients with hepatocellular carcinoma: measurement of serum hepatitis B virus deoxyribonucleic acid (HBV-DNA).
Guan R; Yap I; Wong L; Tan LH; Oon CJ; Wee A
Ann Acad Med Singap; 1989 Jan; 18(1):8-11. PubMed ID: 2540692
[TBL] [Abstract][Full Text] [Related]
38. Significance of HB virus infection in an area of Japan with high incidence of liver cirrhosis and hepatocellular carcinoma: an analysis of consecutive studies among inhabitants of Tomié-Town, Goto Islands.
Munehisa T; Nakata K; Fukahori A; Muro T; Kono K; Furukawa R; Kusumoto Y; Iwanaga A; Ishii N; Koji T
Am J Gastroenterol; 1984 Aug; 79(8):633-6. PubMed ID: 6087656
[TBL] [Abstract][Full Text] [Related]
39. [Incidence of e-antigen and antibodies against it in a selected group of HBsAg-positive Vietnamese citizens].
Michal L; Pullmann R; Szilágyiová M; Konvit I; Straka S; Skraciková J
Cas Lek Cesk; 1991 Jan; 130(3):82-3. PubMed ID: 2004393
[TBL] [Abstract][Full Text] [Related]
40. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
